ClinicalTrials.gg
Active, not recruitingNCT07873437Updated Oct 14, 2026

The Effect of Nutrient Sequencing in Healthy Adults

An interventional study of Finger Prick- Blood Glucose and Whole Blood Draw in Pre Diabetes, sponsored by Cornell University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Cornell University · Not applicable, Interventional, and Prevention

Updated Oct 14, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

There is emerging evidence that the order in which food is consumed in a meal, known as the "nutrient sequence", can have protective health effects against obesity and metabolic disease. These studies show that consuming food sources rich in protein before consuming carbohydrates will significantly lower blood glucose levels equivalent to many glucose-lowering medications. This nutrition intervention can have tremendous therapeutic potential in individuals who are pre-diabetic and prevent the onset of obesity. Surprisingly, however, there are no studies to date that have comprehensively tested this efficacy in young health adults. This research proposal will define the response of nutrient sequencing in young healthy individuals to determine if this intervention can improve metabolic profiles such as normalizing blood glucose levels to healthy parameters in order to prevent obesity and type 2 diabetes. We will 1) test if the metabolic benefits of Nutrient Sequencing can extend across different populations in NY state, and 2) define the mechanism of the metabolic response to nutrient sequencing interventions by capturing participant circulating blood proteome and metabolome.

02

Conditions studied

  • Pre Diabetes

Browse trials for

03

In context

Glucose Intolerance

792 studies on the registry are indexed under Glucose Intolerance; 126 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 656 interventional studies indexed under Glucose Intolerance.

Browse Glucose Intolerance studies →

Lead sponsor

Cornell University is the lead sponsor of 103 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Weight classification as lean or overweight (BMI: 18.5- 29.9)
  • Age range of 18-35 years old

Exclusion criteria

Exclusion Criteria:

  • Self-reported Type I or II diabetes
  • Thyroid dysfunction
  • Bleeding disorders (e.g., Hemophilia A/B, Von Willebrand Disease, or known thrombocytopenia)
  • Use of prescription blood thinners or anticoagulants (e.g., warfarin, heparin, etc.)
  • History of difficulty with blood collection, lab draws, or with prior IV insertion (e.g., 'small veins,' 'hard stick,' etc.)
  • Smoking, recreational drug use, weight loss medications, vaccine administration within last two weeks as these conditions will influence whole body metabolism and compromise dietary response.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Placebo comparator
    Control Diet

    Control Diet: turkey sausage, white bread toast with strawberry jelly, and orange juice consumed in a mixed format within 30min.

    Procedure: Finger Prick- Blood Glucose · Procedure: Whole Blood Draw · Behavioral: Diet History Questionnaire · Behavioral: Physical Activity Assessment

  • Experimental
    Nutrient Sequencing

    Nutrient Sequencing Diet: turkey sausage, white bread toast with strawberry jelly, water. Participants will consume the turkey sausage first and then 10 minutes after they will consume the toast with jelly and orange juice in 20 minutes (Total time = 30 minutes)

    Procedure: Finger Prick- Blood Glucose · Procedure: Whole Blood Draw · Behavioral: Diet History Questionnaire · Behavioral: Physical Activity Assessment

Interventions

  • ProcedureFinger Prick- Blood Glucose

    Measurement of Blood glucose via finger prick

  • ProcedureWhole Blood Draw

    Collection of whole blood for plasma and serum measurements

  • BehavioralDiet History Questionnaire

    Assessment of dietary frequency patterns via DHQ III

  • BehavioralPhysical Activity Assessment

    Assessment of habitual physical activity via IPAQ survey

06

What researchers measure

Primary outcomes

  1. Blood Glucose

    Time frame: Collected via finger prick (5 collection points- Timepoints 0, 30, 60, 90, and 120mins) for both Visit 1 at baseline and Visit 2 which occurs 1 week later after the washout period.

Secondary outcomes

  1. Body Fat Percentage

    Time frame: Collected during Visit 1at baseline via bioelectrical impedance analysis (BIA).

  2. Blood Insulin Levels

    Time frame: Blood collection (3 time point each- Timepoints 0, 30, and 120 mins) during Visit 1 at baseline and Visit 2 after a 1 week washout period. Blood insulin levels will be measured two weeks after Visit 2.

  3. Leptin Blood Measurement

    Time frame: Blood collection (3 time point each- Timepoints 0, 30, and 120 mins) during Visit 1 at baseline and Visit 2 after a 1 week washout period. Blood leptin levels will be measured two weeks after Visit 2.

  4. Healthy Eating Index

    Time frame: Collected during Visit 1 at baseline using the DHQIII diet frequency questionnaire.

07

Study locations

1 site
  • Cornell University
    Ithaca, New York 14850, United States
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07873437
Lead sponsor
Cornell University
Responsible party
Sponsor
First posted
Oct 14, 2026
Start date
Sep 1, 2026
Primary completion
Oct 1, 2028 (estimated)
Completion
Oct 1, 2028 (estimated)
Last update
Oct 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion